•
Dec 31, 2021

Solid Biosciences Q4 2021 Earnings Report

Total Revenue
$3.15M
Previous year: $98.3M
-96.8%
EPS
-$2.55
Previous year: -$4.65
-45.2%
Gross Profit
-$41M
Cash and Equivalents
$119M
Previous year: $155M
-23.0%
Free Cash Flow
-$21.5M
Previous year: $1.25M
-1826.9%
Total Assets
$232M
Previous year: $171M
+35.8%

Solid Biosciences

Solid Biosciences